Cancer Research Meeting Calendar  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 3495-3499, August 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iozzo, R. V.
Right arrow Articles by Danielson, K. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iozzo, R. V.
Right arrow Articles by Danielson, K. G.

Aberrant Expression of the Growth Factor Wnt-5A in Human Malignancy1

Renato V. Iozzo2, Inge Eichstetter and Keith G. Danielson

Department of Pathology, Anatomy, and Cell Biology and the Jefferson Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107

The Wnt-5A gene codes for a secreted cysteine-rich growth factor that mediates cell to cell signaling via a paracrine mechanism during development and ontogeny. We have recently determined the genomic organization and chromosomal mapping of the human Wnt-5A, and observed distinct patterns of expression in developing human embryos. In this report, we have performed a detailed expression analysis of 100 adult human tissues and tumors and 10 human cell lines. Our data show a widespread expression of Wnt-5A in adult tissues and cells, and aberrant mRNA levels in lung, breast, and prostate carcinomas and in melanomas. The up-regulation of Wnt-5A in human malignancy was not due to either gene rearrangement or amplification. These findings document an abnormal expression of this growth factor in malignancy and implicate Wnt-5A in the genesis of human cancer.

1 This work was supported by NIH Grants RO1 CA39481 and RO1 CA47282 (R. V. I.). R.V.I. is a recipient of a Faculty Research Award (FRA-376) from the American Cancer Society.

2 To whom requests for reprints should be addressed, at Department of Pathology, Anatomy, and Cell Biology, Room 249, Jefferson Alumni Hall, Thomas Jefferson University, 1020 Locust Street, Philadelphia, PA 19107.

Received 4/20/95. Accepted 6/28/95.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
R Z Karim, S K Gerega, Y H Yang, L Horvath, A Spillane, H Carmalt, R A Scolyer, and C S Lee
Proteins from the Wnt pathway are involved in the pathogenesis and progression of mammary phyllodes tumours
J. Clin. Pathol., November 1, 2009; 62(11): 1016 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. L. Schwartz, R. Malgor, E. Dickerson, A. T. Weeraratna, A. Slominski, J. Wortsman, N. Harii, A. D. Kohn, R. T. Moon, F. L. Schwartz, et al.
Phenylmethimazole Decreases Toll-Like Receptor 3 and Noncanonical Wnt5a Expression in Pancreatic Cancer and Melanoma Together with Tumor Cell Growth and Migration
Clin. Cancer Res., June 15, 2009; 15(12): 4114 - 4122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Cao, C. Chiarelli, O. Richman, K. Zarrabi, P. Kozarekar, and S. Zucker
Membrane Type 1 Matrix Metalloproteinase Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer
J. Biol. Chem., March 7, 2008; 283(10): 6232 - 6240.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Ying, H. Li, J. Yu, K. M. Ng, F. F. Poon, S. C. C. Wong, A. T.C. Chan, J. J.Y. Sung, and Q. Tao
WNT5A Exhibits Tumor-Suppressive Activity through Antagonizing the Wnt/ -Catenin Signaling, and Is Frequently Methylated in Colorectal Cancer
Clin. Cancer Res., January 1, 2008; 14(1): 55 - 61.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
H. Yoshikawa, K. Matsubara, X. Zhou, S. Okamura, T. Kubo, Y. Murase, Y. Shikauchi, M. Esteller, J. G. Herman, X. Wei Wang, et al.
WNT10B Functional Dualism: beta-Catenin/Tcf-dependent Growth Promotion or Independent Suppression with Deregulated Expression in Cancer
Mol. Biol. Cell, November 1, 2007; 18(11): 4292 - 4303.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. D. McCall, N. Harii, C. J. Lewis, R. Malgor, W. Bae Kim, M. Saji, A. D. Kohn, R. T. Moon, and L. D. Kohn
High Basal Levels of Functional Toll-Like Receptor 3 (TLR3) and Noncanonical Wnt5a Are Expressed in Papillary Thyroid Cancer and Are Coordinately Decreased by Phenylmethimazole Together with Cell Proliferation and Migration
Endocrinology, September 1, 2007; 148(9): 4226 - 4237.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S Ripka, A Konig, M Buchholz, M Wagner, B Sipos, G Kloppel, J Downward, T. Gress, and P Michl
WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer
Carcinogenesis, June 1, 2007; 28(6): 1178 - 1187.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
T. N. H. Masckauchan, D. Agalliu, M. Vorontchikhina, A. Ahn, N. L. Parmalee, C.-M. Li, A. Khoo, B. Tycko, A. M.C. Brown, and J. Kitajewski
Wnt5a Signaling Induces Proliferation and Survival of Endothelial Cells In Vitro and Expression of MMP-1 and Tie-2
Mol. Biol. Cell, December 1, 2006; 17(12): 5163 - 5172.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Kurayoshi, N. Oue, H. Yamamoto, M. Kishida, A. Inoue, T. Asahara, W. Yasui, and A. Kikuchi
Expression of Wnt-5a Is Correlated with Aggressiveness of Gastric Cancer by Stimulating Cell Migration and Invasion
Cancer Res., November 1, 2006; 66(21): 10439 - 10448.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. Leandersson, K. Riesbeck, and T. Andersson
Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells
Nucleic Acids Res., September 1, 2006; 34(14): 3988 - 3999.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Pukrop, F. Klemm, Th. Hagemann, D. Gradl, M. Schulz, S. Siemes, L. Trumper, and C. Binder
Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines
PNAS, April 4, 2006; 103(14): 5454 - 5459.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. M. Bachmann, O. Straume, H. E. Puntervoll, M. B. Kalvenes, and L. A. Akslen
Importance of P-Cadherin, {beta}-Catenin, and Wnt5a/Frizzled for Progression of Melanocytic Tumors and Prognosis in Cutaneous Melanoma
Clin. Cancer Res., December 15, 2005; 11(24): 8606 - 8614.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C.-l. Huang, D. Liu, J. Nakano, S. Ishikawa, K. Kontani, H. Yokomise, and M. Ueno
Wnt5a Expression Is Associated With the Tumor Proliferation and the Stromal Vascular Endothelial Growth Factor--An Expression in Non-Small-Cell Lung Cancer
J. Clin. Oncol., December 1, 2005; 23(34): 8765 - 8773.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Zi, Y. Guo, A. R. Simoneau, C. Hope, J. Xie, R. F. Holcombe, and B. H. Hoang
Expression of Frzb/Secreted Frizzled-Related Protein 3, a Secreted Wnt Antagonist, in Human Androgen-Independent Prostate Cancer PC-3 Cells Suppresses Tumor Growth and Cellular Invasiveness
Cancer Res., November 1, 2005; 65(21): 9762 - 9770.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Farago, I. Dominguez, E. Landesman-Bollag, X. Xu, A. Rosner, R. D. Cardiff, and D. C. Seldin
Kinase-Inactive Glycogen Synthase Kinase 3{beta} Promotes Wnt Signaling and Mammary Tumorigenesis
Cancer Res., July 1, 2005; 65(13): 5792 - 5801.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Liu, A. Bafico, and S. A. Aaronson
The Mechanism of Endogenous Receptor Activation Functionally Distinguishes Prototype Canonical and Noncanonical Wnts
Mol. Cell. Biol., May 1, 2005; 25(9): 3475 - 3482.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Dejmek, K. Leandersson, J. Manjer, A. Bjartell, S. O. Emdin, W. F. Vogel, G. Landberg, and T. Andersson
Expression and Signaling Activity of Wnt-5a/Discoidin Domain Receptor-1 and Syk Plays Distinct but Decisive Roles in Breast Cancer Patient Survival
Clin. Cancer Res., January 15, 2005; 11(2): 520 - 528.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. G. Horvath, S. M. Henshall, J. G. Kench, D. N. Saunders, C.-S. Lee, D. Golovsky, P. C. Brenner, G. F. O'Neill, R. Kooner, P. D. Stricker, et al.
Membranous Expression of Secreted Frizzled-Related Protein 4 Predicts for Good Prognosis in Localized Prostate Cancer and Inhibits PC3 Cellular Proliferation in Vitro
Clin. Cancer Res., January 15, 2004; 10(2): 615 - 625.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
K Pham, T Milovanovic, R J Barr, T Truong, and R F Holcombe
Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features
Mol. Pathol., October 1, 2003; 56(5): 280 - 285.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Jonsson, J. Dejmek, P.-O. Bendahl, and T. Andersson
Loss of Wnt-5a Protein Is Associated with Early Relapse in Invasive Ductal Breast Carcinomas
Cancer Res., January 1, 2002; 62(2): 409 - 416.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. Julicher, G. Marquitan, N. Werner, W. Bardenheuer, L. Vieten, F. Brocker, H. Topal, S. Seeber, B. Opalka, and J. Schutte
Novel Tumor Suppressor Locus in Human Chromosome Region 3p14.2
J Natl Cancer Inst, September 15, 1999; 91(18): 1563 - 1568.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. C. Humphreys, J. Lydon, B. W. O’Malley, and J. M. Rosen
Mammary Gland Development Is Mediated by Both Stromal and Epithelial Progesterone Receptors
Mol. Endocrinol., June 1, 1997; 11(6): 801 - 811.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.